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Summary 
Introduction During the last years it has become increasingly clear that different 
tissues in the body communicate with other tissues via hormonal signals synthesized 
and secreted to the blood as demonstrated in the last decade for the adipose tissue. 
Skeletal muscle accounts for approximately 40 % of the body weight of a normal 
weight fit person. It is known that exercise offers protection against chronic disorders 
such as cardiovascular diseases, type 2 diabetes, dementia, and depression. It is 
unclear how contracting skeletal muscles mediate metabolic effects of benefits on 
health, which has been called the work stimulus, the work factor or the exercise 
factor. It has been shown that muscle fibres produce and release the cytokine IL-6 
into the circulation during exercise. It is also possible that released myokines may 
explain how regular muscle activity can influence mood, performance, and cognitive 
function. 
Aims The aims of this study were to investigate the release of peptides and proteins 
by human myotubes in culture and further study the effect of energy-carrying 
metabolites on the release. 
Methods By analyzing the conditioned media by using proteomic analysis and 
ELISAs, we could measure the release of proteins from human myotubes in culture. 
We also used Brefeldin A (BFA) to further explore whether the release was due to 
secretion or due to leak because of cell damage.  
Results The mean concentration of IL-6 from myotubes incubated in medium 
without BFA was 19 and 11 times higher than the concentration derived from 
myotubes incubated in medium with BFA, when incubating 3 and 6 hours, 
respectively. IL-6, IL-8, IL-7 and IL-13 were detected by Luminex Multiplex 
technology. 
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Conclusion We have during this work optimized several conditions important to 
concider when using myotubes as a model for identifying novel myokines. In 
addition to IL-6 we detected some potentially new myokines which are; 
 IL-7, IL-8 and IL-13.  Our studies support the theory that myotubes release proteins 
with possible hormonal functions, and that the release perhaps can be influenced by 
different energy carrying metabolites.  
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1. Introduction 
 
 
During the last years it has become increasingly clear that different tissues in the 
body communicate with other tissues via hormonal signals synthesized and secreted 
to the blood as demonstrated for the adipose tissue (1;2) 
Several lines of evidence indicate that exercise promotes health (3-5). Some of the 
good consequences of regular exercise are greatly improved muscle tone, better 
posture, more efficient heart and lung function, less fatigue, and looking and feeling 
better. It is also known that exercise offers protection against chronic disorders such 
as cardiovascular diseases, type 2 diabetes, dementia and depression. The 
mechanisms for these health benefits are not fully understood. One of the possible 
explanations for the health benefit of exercise can be that regular muscle contraction 
mediates important messengers (6). 
Muscle is a very specialized tissue that has both the ability to contract and the ability 
to conduct electrical impulses. Muscles are classified functionally as voluntary or 
involuntary, and structurally as either striated or smooth muscle cells. Muscles 
perform at least three essential functions in the body: contraction causing movement 
or providing posture, and heat production. Skeletal muscle accounts for 
approximately 40 % of the body weight of a normal weight fit person (7). Skeletal 
muscle is a type of striated muscle, usually attached to the skeleton. They generally 
contract voluntarily, via somatic nerve stimulation, although they can contract 
involuntarily via reflexes. 
A skeletal muscle is composed of bundles of muscle fibers that generally extend the 
entire length of the muscle. They are called fibers, instead of cells, because of their 
threadlike shape. They can be 1 to 40 cm long but they have a diameter of only 10 to 
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100 um. Muscle cells contain network of tubules and sacs known as the sarcoplasmic 
reticulum a structure analogous but not identical to the endoplasmatic reticulum of 
other cells. Muscle fibers contain many mitochondria and, unlike most other cells, 
they have several nuclei. 
  
 
 
 
 
 
 
 
 
Illustration 1.                                                                                                                                                
Within each muscle cell are a myriad of tiny filaments encased in structures called myofibrils. The muscle fiber 
contains a lot of mitochondria (illustrated) and several nuclei (not illustrated). Illustration by Karen Wehrstein. 
 
Skeletal muscle fibers can be classified in three types according to their structural and 
functional characteristics; slow, fast and intermediate fibers. Although all muscles 
contain a mix of all three fiber types, they have different proportions depending on 
the types of contraction that they most often perform. 
Slow fibers are also called red fibers, because they contain a high concentration of 
myoglobin, the reddish pigment used by muscle cells to store oxygen. They are called 
slow fibers because their thick myofilaments are made of a type of myosin that reacts 
at a slow rate. Because red fibers contract slowly, they are usually able to produce 
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ATP quickly enough to keep pace with the energy needs, and thereby avoid fatigue. 
This effect is enhanced by a larger number of mitochondria than other fibertypes and 
by the myoglobin-bound oxygen. Red fibers are well suited for chronically 
contractions and can hold the body upright for a long period without fatigue.  
Fast fibers contain little myoglobin and contract much more rapidly than red fibers 
because they have a faster type of myosin. The fast fibers can rapidly be depleted of 
ATP during contraction and can not sustain contraction for a long time. This is 
because they quickly build up lactate due to increased glycolysis. 
Intermediate fibers have characteristics in between the two extremes of fast and slow 
fibers. This type of fibers dominates in muscles that provide postural support and are 
occasionally required to generate rapid, powerful contractions (7). 
Adult skeletal muscle is capable of self-repair in response to extreme training, injury 
or diseases such as muscular dystrophy. The ability for self-repair or regeneration is 
due to a population of satellite cells. The satellite cells are quiescent but become 
activated when a myofiber is injured. When myofiber repair or regeneration is needed 
the satellite cells activate, proliferate, and then withdraw from the cell cycle to form 
differentiated myotubes, and ultimately restore the skeletal muscle architecture (8). 
When the muscle fiber is not injured the satellite cell is quiescent and rests in an 
indentation in the muscle fiber. The satellite cells can be distinguished from the 
myonuclei by a surrounding basal lamina and more abundant heterochromatin. 
Satellite cells become activated and increase their cytoplasmic content when the fibre 
becomes injured. The cytoplasmic processes allow chemotaxis of the satellite cell 
along the myofiber (9). 
Quiescent satellite cells express CD34, Pax7, and Myf5/ß-gal. Pax7 is probably the 
most useful current marker for quiescent satellite cells due to the availability of a 
good antibody. When satellite cells are activated, they rapidly initiate MyoD 
expression, whereas myogenin later marks the commitment to differentiation.  
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Illustration 2. A schematic presentation of satellite cell markers as they transit from quiescence to 
differentiation. Satellite cells are quiescent in normal adult muscle and can be activated by, for example, 
muscle damage. Once activated, satellite cells divide to produce satellite cell-derived myoblasts that further 
proliferate, before committing to differentiation and fusing to form myotubes, which then mature into 
myofibers. CD34, Pax7, and Myf5/ß-gal are expressed in quiescent satellite cells. Satellite cell activation is 
marked by the rapid onset of MyoD expression, whereas myogenin later marks the commitment to 
differentiation (10). 
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The satellite cells seeded out in culture are grown in a specialized medium and the 
change from one type of medium to another initiate the differentiation of the 
myoblasts. 
 
 
 
 
 
Picture 1. Human skeletal satellite cells seeded out in 12 well plate. To the left; undifferentiated satellite 
cells. To the right; differentiated myotubes. Photo by Vigdis Aas. 
 
Skeletal muscle atrophy can occur under many different conditions, including 
prolonged immobilization, denervation, cachexia, cushingoid conditions or with 
advanced age. The word ‘‘cachexia’’ is derived from the Greek ‘‘kakos’’ meaning 
‘‘bad’’ and ‘‘hexis’’ meaning ‘‘condition’’. Cachexia is the cytokine-associated 
wasting of protein and energy stores. Systemic inflammation mediated through cell 
injury or activation of the immune system triggers an inflammatory response. Persons 
with cachexia loose roughly equal amounts of fat and fat-free mass, while 
maintaining extracellular water and intracellular potassium. The loss of fat-free mass 
is mainly from the skeletal muscle. Cachexia due to cancer may deplete up to 80% of 
their muscle mass (11). The loss of skeletal muscle mass is due to a combination of 
reduced protein synthesis and increased protein degradation, the latter being the 
major factor (11). 
 In addition to the effect of cytokines on skeletal muscle, cytokines act in the 
hypothalamus to cause an imbalance between the orexigenic and anorexigenic 
regulatory pathways. In anorexia-cachexia syndrome, the peripheral signals for an 
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energy deficit reaching the hypothalamus fail to produce a response, which 
propagates the cachectic process. Despite a falling energy intake, patients with 
cachexia frequently show elevated resting energy expenditure as a result of increased 
Cori cycle activity, glucose and triglyceride-fatty acid cycling and gluconeogenesis. 
A number of cytokines, including tumor necrosis factor-α (TNF-α), interleukins 1 and 
6 (IL-1 and IL-6), interferon γ (IFN-γ), and leukaemia-inhibitory factor (LIF), have 
been proposed as mediators of the cachectic process (12). IL-6 has the potential to act 
as a cachectic factor. In an in vitro study (13) using C2C12 myotubes, incubation of 
the cells to recombinant human IL-6, shortened the half-life of long-lived proteins 
and increased the proteolytic activity. This suggests that IL-6 is capable of up-
regulating protein degradation. The results indicate that IL-6 may be active in the 
cachectic process. However, IL-6 probably does not act alone but may either induce 
or act in synergy with other cachectic factors (12). 
Muscular dystrophies are inherited disorders characterized by muscle degeneration 
and associated progressive wasting and weakness. The most common form is 
Duchenne muscular dystrophy (DMD), affecting 1/3500 newborn males. It is caused 
by the dystrophin gene encoding a large protein that is crucial for the assembly of a 
cell surface complex connecting the muscle fibre cytoskeleton to the overlying basal 
lamina. In the absence of dystrophin, muscle fibres undergo repeated cycles of 
degeneration accompanied by regeneration involving extensive proliferation of 
muscle precursor cells, but also a chronic inflammatory response and cytokine 
production. This inflammation is associated with synthesis of extracellular matrix 
(ECM) molecules. Excessive accumulation of EMC in the interstitial space was the 
basis of the original description of this disease as myosclerosis (7).  
Se-Jin Lee found in 1997 that the strong Belgian Blue and Piedmontese cattle strains 
had a defective myostatin gene; these strains have been produced through breeding. 
The mutated myostatin led to abnormal muscle growth (14;15). Myostatin (growth 
differentiation factor-8) is a secreted growth factor belonging to the transforming 
growth factor-  (TGF- ) superfamily that acts as a negative regulator of skeletal 
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muscle mass. Human myostatin consists of two identical subunits with 110 amino 
acid residues and has a total molecular weight of 25.0 kDa. A number of natural, 
inactivating mutations have been identified in cattle, mouse, sheep and human, all 
leading to a hypermuscular phenotype. The biological relevance of myostatin was 
also addressed in mice by gene inactivation, overexpression of normal or dominant-
negative forms and systemic administration of inactivating antibody or myostatin 
protein. From these studies and many others carried out in cultured cells, the general 
conclusion is that myostatin regulates the final number of muscle fibers during 
development by blocking the proliferation and differentiation of myoblasts and also 
regulates the postnatal muscle-fiber size by maintaining the satellite cells in a 
quiescent state and inhibiting protein synthesis. Considering its effect on muscle 
growth, inhibition of myostatin has a tremendous potential as a therapeutic approach 
in muscle-degenerative and wasting conditions, such as muscular dystrophies and 
cachexia. (16;17)  
1.1 Myokines 
In vivo studies have shown that muscle tissue release peptides and proteins during 
exercise (18).  In line with that adipokines have been suggested as a term to cover 
proteins that are produced and secreted by adipocytes, we suggest that the term 
“myokines” should be restricted as a collective term to describe proteins that are 
produced and released by muscle fibres per se.  
The cytokine IL-6 is produced and released by muscle fibres into the circulation 
during exercise (18). Plasma levels of IL-6 increase exponentially up to 100-fold in 
relation to an acute bout of exercise. The size of the response depends on the 
intensity, duration, and the mode of exercise. The IL-6 transcription rate is markedly 
enhanced when glycogen levels are low (19).  
Physical exercise is associated with a systemic cytokine response comparable with the 
levels observed during severe infections. One important difference is that the levels 
 14 
of TNF-  and IL-1ß are increased for a short period (minutes) if present at all when 
concentric exercise without muscle damage is performed. This indicates that in non-
traumatic exercise models, the cytokine cascade differs markedly from the classical 
acute-phase response studied during infections (6;18). 
IL-6 is an important pleiotropic cytokine with both pro- and anti-inflammatory 
properties. Increased circulating levels of IL-6 have been reported in severely ill 
patients suffering from injury, sepsis, cachexia, or cancer.(20). Muscle-derived IL-6 
is considered to possess a central role in anti-inflammatory activities and health 
beneficial effects in relation to physical activity (6). 
IL-6 is a member of a family of cytokines that consists of leukaemia inhibitory factor, 
IL-11, ciliary neurotropic factor, oncostatin M, and cardiotrophin 1 (21). Their 
membership is based on similarities in helical protein structure and a shared receptor 
subunit (22). IL-6 is a variably glycosylated protein with a molecular mass of 22–27 
kDa depending on the cellular source and amount of post-translational modification. 
It is synthesized as a precursor protein of 212 amino acids (aa), with a 28 aa signal 
sequence and a 184 aa mature segment (23). IL-6 is produced by many different cells, 
but the main sources in vivo are stimulated monocytes/macrophages, fibroblasts, and 
vascular endothelial cells, indicative of its role in the modulation of the immune 
system. Other cells known to express IL-6 include keratinocytes, osteoblasts, T cells, 
B cells, neutrophils, eosinophils, mast cells, smooth muscle cells (24) in addition to 
skeletal muscle cells (25) Several studies have shown that adipose tissue also 
produces and secretes IL-6, and that 10-35% of the body basal circulating IL-6 is 
derived from adipose tissue (20).  
IL-6 increases glucose metabolism in resting human skeletal muscle, as well as 
increasing transport of glucose into skeletal muscle, glucose incorporation into 
glycogen, and glucose oxidation (14). AMP-activated protein kinase (AMPK) is a 
fuel-sensing enzyme that is activated by changes in the energy status of a cell and by 
exposure to hormones as adiponectin and leptin, and catecholamines. Once activated, 
AMPK stimulates a variety of processes that increase ATP generation including fatty 
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acid oxidation and glucose transport in skeletal muscle cells (26). Data demonstrate 
that exercise activates transcription of the IL-6 gene in working skeletal muscle, a 
response that is dramatically enhanced when glycogen levels are low (27). Both IL-6 
production and AMPK activity increase to the intensity and duration of exercise and 
are further enhanced when glycogen levels are low (26). 
Proteins measured in plasma from working skeletal muscles can derive from muscle 
cells, either by leak or secretion, or from other kinds of cells in the muscle tissue e.g. 
macrophages. Studies have shown that proteins can derive from both skeletal muscle 
tissue and from muscle cells in culture (18;20;28). Proteins in plasma that are 
synthesized in skeletal muscles can not unconditionally be classified as myokines 
because they can be derived from cells other than muscle fibres. Another study by De 
Rossi et al. indicated that IL-8 was released by human myotubes in culture (29), but 
they did not show whether this release was due secretion or leakage from damaged 
cells.  
In our study we want to find out more about the release and secretion of proteins 
from myotubes in culture. This will give us more information about myokines 
because in culture we know that the proteins we measure are derived from the muscle 
cells, and we can determine whether the release is due leak or secretion.  
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1.2 Aims 
1.2.1 Study release of peptides and proteins by human myotubes 
in culture 
The first object of this study was to investigate if we could detect proteins released 
from cultured human myotubes in our model.  
 
1.2.2 Study the effect of energy-carrying metabolites on the 
release of proteins from human myotubes in culture 
The second object was to incubate myotubes with energy-carrying nutrients and 
examine how this will influence the release of myokines.  
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2. Materials and methods 
2.1 Materials 
Dulbecco’s modified eagle medium with L-Glutamine (DMEM), 10 % foetal calf 
serum (FCS) and penicillin-streptomycin 5000IU/mL - 5mg/mL was obtained from 
Sigma Chem, St.Lois, MO, USA. Ultroser G was obtained from BioSepra, Ciphergen 
Biosystem Inc, Paris, France. Extracellular matrix gel (ECM), essentially fatty acid 
free bovine serum albumin, bovine serum albumin (used for protein standard) Sigma 
Chem. Co, palmitic acid (PA), oleic acid (OA), eicosapentaic acid (EPA),  DHA was 
obtained from Nu-Chek prep, Inc, Elysian, MN, USA. 14C labelled BSA was 
delivered by Perkin Elmer, Waltham, Massachusetts 02451 USA. Insulin Actrapid 
was obtained from Novo Nordisk, Bagsværd, Denmark. Trizol reagent was purchased 
from Invitrogen, Carlsbad, CA, USA. Bio-Rad protein assay dye reagent concentrate 
was obtained from Bio-Rad Laboratories, CA, USA. 12-well plates were obtained 
from Corning, NY, USA. Total protein was measured with Titertek Multiskan, 
Labsystems Oy, Helsinki, Finland. Cell Bind Flasks Corning, NY, USA. DMEM w/o 
glucose, phenol red, L-Glutamine, Sigma Chem. Co and IL-6 immunoassay, came 
from R&D Systems, MN, USA. Multiplex Immunoassay was from Lincoplex, St. 
Charles. Missouri, USA, and glucose was delivered by Sigma Chem. Co, the LDH-kit 
was delivered by Roche Diagnostics, Roche Applies Science, Mannheim, Germany, 
whereas RD 193058100 Human Myostatin ELISA came from BioVendor. For 
protein assay, the BC Assay protein kit was obtained from Uptima Interchim, 
Montluçon, France. 
 
A cell bank of satellite cells was established from muscle biopsy samples taken from 
musculus vastus lateralis or m. obliqulus internus abdominis from healthy volunteers, 
aged 24.7 ± 0.7 years with body mass index 23.6 ± 1.1 kg/m2. The biopsies were 
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obtained with informed consent and approval by the National Committee for Research 
Ethics (Oslo, Norway). Muscle cell cultures free of fibroblasts were established by 
the method of Henry et al. with minor modifications. The cells were cultured in a 
humidified 5% CO2 atmosphere at 37°C, and medium was changed every 2–3 days. 
Medium 1 (M1) for seeding 
500 mL DMEM with low glucose (SIGMA, #D6046), 50 mL FCS (Foetal Calf 
Serum (SIGMA, #F7524), 5 mL L-glutamine (SIGMA, #G7513, 100 mL), 5 mL 
Penicillin/Streptomycin (GIBCO BRL, #15140-114, 100 mL) 
M2 for proliferation 
500 mL DMEM with low glucose (SIGMA, #D6046), 10 mL FCS (Foetal Calf 
Serum (SIGMA, #F7524), 10 mL Ultroser G, 5 mL L-glutamine (SIGMA, #G7513, 
100 mL, 5 mL Penicillin/Streptomycin (GIBCO BRL, #15140-114, 100 mL) 
M3 for differentiation 
500 mL DMEM with low glucose (SIGMA, #D6046), 10 mL FCS (Foetal Calf 
Serum (SIGMA, #F7524), 5 mL L-glutamine (SIGMA, #G7513, 100 mL), 5 mL 
Penicillin/Streptomycin (GIBCO BRL, #15140-114, 100 mL, 25 pmol Insulin (⇒21 
µl of 1000 x diluted Insulin Actrapid, Novo Nordisk, 0,6 mM) 
Ultroser-G (Bio Serpa, #P/N 15950-017) should be re-constituted by adding of 20 
mL MQW to the container. Wait for 15 minutes, and transfer 10 mL to M2-medium. 
The rest (10 mL) is frozen (-20 °C) for further use. 
2.2 Methods 
To study the in vitro secretion of myokines from human skeletal muscle cells, we had 
to make a model appropriate for our hypothesis. We performed a few experiments 
before we selected a model that would function for both analysis in the laboratory at 
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UiO and for the analysis at the Hormonlaboratorium at Aker University hospital. 
Earlier experiments performed by Vigdis Aas and colleges indicated that it was 
important to remove as much protein from serum in the media as possible before the 
analysis at Aker University Hospital. This was necessary to reduce the background 
noise from FCS proteins (mainly BSA) during 2D-gel electrophoresis. Thus, to find 
possible proteins derived from myotubes in the supernatant, albumin and other 
proteins from the serum in the medium had to be removed from the supernatant 
before the samples could be analyzed at Aker by 2D-gel electrophoreses. To remove 
serumprotein we had to decide the optimal numbers of washes each well should 
receive. Some other things we had to find out were how many days the cells should 
be differentiated before experiments were performed, how long time the cells would 
stay viable without serum, at what concentrations of the different components given 
to the myotubes, and how we could explore whether the cells were leaking or 
secreting the proteins in media.  
We performed several experiments to find answers to the questions above but also to 
learn the techniques. The differentiation medium contained abundant amounts of 
exogenous serum-derived proteins that had to be removed before analysis of myokine 
secretion could be performed. Especially albumin was potentially troublesome 
because it would generate a relatively high background if not properly removed by 
washing. Thus, it was very important to evaluate the washing procedure with respect 
to the removal of exogenous proteins. Extensive washing can be harmful to the cells, 
and therefore the aim was to find the number of wash-cycles that sufficiently 
removed the albumin without significantly reducing cell viability. 
 
2.2.1 Seeding satellite cells 
The muscle cells used in this model were satellite cells isolated from biopsy samples 
from m. obliqulus internus abdominis or m. vastus lateralis. The satellite cells had to 
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be treated in a special manner to manage to grow and differentiate and we followed 
the procedure as follows; 
Procedure 
1. 1 vial containing the satellite cells (approximately 1.5 million cells) was picked 
up from the tank containing liquid nitrogen. 
2. The suspension was thawed in 37 ˚ C until only a tiny piece of ice was left. 
3. In a LAF bench the cell suspension was added to a 50 mL tube containing 9 mL 
or 15 mL prewarmed M1 depending on the format used (12 well plate or 75 
cm2 flask). This was performed to avoid the cells to be exposed to the high 
concentration of DMSO which is poisonous for the cells when they are not 
frozen. The cell suspension was well mixed with M1 by a pipette. 
4. The cells were seeded with 750 ul medium in each well in the 12 well plate and 
15 mL in the 75 cm2 flask and incubated in 37˚C and 5% CO2 over night. 
5. The day after the medium was changed from M1 to 1 mL M2. M2 was changed 
every second or third day. 
6. When the cells had reached 80% confluence the medium was changed to either 
1 mL M3 for the 12 well plate or 15 mL for the flask. When changing medium 
to M3 at this point the cells differentiated into multinucleated myotubes. The 
M3-medium was changed every second or third day.  
7. The experiments were performed either before M3-medium were given (0-days 
differentiating cells) up to 5-days differentiated cells. Different substances 
were added to either M3 or DMEM according to the experiment performed. 
The cells were visually inspected under microscope during growth, 
differentiation and experiments. 
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2.2.2 Monitoring cell damage by LDH activity 
The myotubes were exposed to various potentially harmful substances in the different 
experiments. To monitor their well being we used Cytotoxicity Detection Kit that 
measures how much of the intracellular enzyme lactate dehydrogenase (LDH) is 
leaking through the membrane. This can be used as a general marker on whether the 
cells are doing all right or not.   
Protocol: 
1. After the media, which the myotubes had incubated in, were centrifuged on 
3000 rpm for 5 min, and the muscle cells lysated in 100-1000 ul 2% Triton X-
100, 20 ul and 25 ul from the lysate and supernatants, respectively were 
transferred to a flat bottom 96-well plate. 
2. To each well 25-30 ul milliQ water and 50 ul LDH reagents were added 
3. The 96-well plate incubated in 37˚C for 15 minutes 
4. The absorbance was measured by a spectrophotometer (Titertec) 
5. Blank background samples consisting of either only DMEM or lysis-solution 
were measured in parallel and the value were subtracted from the respective 
values from the samples 
 
2.2.3 Protein quantification of the lysates 
BC (bicinchoninic acid) Assay and Bio-Rad Assay were used to determine the 
amount of protein in samples. 
The BC-reagent reduces Cu2+ in alkaline solutions to Cu+ and two molecules of 
BCA interact with each molecule of Cu+ forming a water soluble red complex.  
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The Bio-Rad Protein Assay is a dye-binding assay in which a differential colour 
change occurs in response to the concentration of protein. Coomassie blue dye binds 
to primarily basic amino acid residues, especially arginine. 
Protocol: 
Cell lysates were homogenised and 25 ul of each homogenate was transferred to 
separate wells on a flat bottom 96-wells plate.  
Protein standards made from BSA by serial dilution were likewise added to separate 
wells. 
Each well was added 200 ul reconstituted coomassie reagent or BC-reagent, and the 
plate was then incubated at room temperature (5 or 30 min for Coomassie and BC-
reagent, respectively). 
 The absorbance values were determined by a spectrophotometer (Titertec) at either 
590 nm (Coomassie) or 490 nm (BC). 
 Sample protein concentrations were determined by plotting the absorbance values 
into the linear function obtained from the protein standards. 
 
2.2.4 IL-6 measurement  
ELISA is a sensitive immunoassay that uses an enzyme linked to an antibody as a 
marker for the detection of a specific protein. 
This assay employs the quantitative sandwich enzyme immunoassay technique. A 
monoclonal antibody specific for IL-6 has been pre-coated onto a microplate. 
Standards and samples were pipetted into the wells, and any IL-6 present was bound 
by the immobilized antibody. 
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The samples were compared against the standards curve to determine the amount of 
IL-6 present. Results were expressed in pg/mL. The lower detection limit was 0.07 
pg/mL. 
 
Protocol 
1 100 ul Assay Diluent were added to the wells 
2. 200 ul of Standard, sample or control were added per well 
3. The wells were washed by a washing procedure as follows; 
a. Removing liquid from the wells by inverting the plate and decanting the contents. 
b. Removing excess liquid by grasping the plate firmly and smartly rapping the plate 
inverted on a clean paper towel at least 5 times. 
c. Filling each well with 400 ul of Wash Buffer using a multi-channel pipette 
d. Removing liquid from the wells by inverting the plate and decanting the contents. 
e. Repeating steps b, c, and d 3 times for a total of 4 washes. After the last wash, 
smartly rap the plate inverted on a clean paper towel at least 10 times to remove 
excess Wash Buffer. 
4. 200 ul of GM-CSF Conjugate were added to each well. The plate was covered with 
a new adhesive strip and incubated for 2 hours at room temperature. 
5. The wash steps above were repeated. 
6. 50 ul of Substrate Solution were added to each well. The plate was covered with a 
new adhesive strip and incubated for 1 hour at room temperature.  
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7. 50 ul of Amplifier Solution were added to each well and covered with a new 
adhesive strip and incubate for 30 minutes at room temperature. Addition of 
Amplifier Solution initiated colour development. 
8. 50 ul of Stop Solution were added to each well. Addition of Stop Solution does not 
affect the color in the wells. 
9. The optical density of each well was determined within 30 minute, using a 
microplate reader set to 490 nm.  
 
2.2.5 Brefeldin A (BFA) was utilized to explore protein secretion 
from myotubes 
BFA is a lactone antibiotic produced by fungal organisms. BFA interferes with 
protein transport from endoplasmatic reticulum to Golgi apparatus and leads to 
accumulation of proteins inside ER. In mammalian cells BFA inhibits activation of a 
GTPase which recruits coat proteins to intracellular membranes and is therefore 
involved in the formation of transport vesicles. Because BFA inhibits protein 
transport and secretion of proteins, we can get an indication on whether the proteins 
found in the media is due to leak or secretion. 
The myotubes were added incubation medium with or without 1 ug/mL BFA. By 
comparing the amount of protein measured in the media from the two treatments we 
can explore the secretion of different peptides and proteins derived from myotubes. 
 
2.2.6 Cytokine measurements 
High sensitivity human cytokine multiplex immunoassay kit may be used for 
analyses of many cytokines in culture supernatants simultaneously. The cytokines 
 25
tested were IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12(p70), IL-13, IFNγ, 
GM-CSF and TNFα. 
Procedure 
1. The filter was pre-wet by pipetting 200 ul of 1X Wash Buffer into each well of 
the microtiter plate 
2. The plate was sealed and put on a plate shaker for 10 minutes at room 
temperature. 
3. Wash Buffer was removed by vacuum. 
4. The bead bottle was sonicated for 30 seconds and vortexed for 1 minute.  
5. 25 ul of the mixed beads were added to each well. 
6. Liquid was removed from the wells by vacuum. 
7. 50 ul Assay Buffer were added to the 0 Standard and the sample wells. 
8. 50 ul of each Standard and Control were added to appropriate wells. 
9. 50 ul matrix solution were added to the Background, Standards, and Control 
wells. 
10. The plate was covered with aluminium foil and incubated with agitation on a 
plate shaker overnight (19 hr) 
11. The fluid was removed by vacuum aspiration. 
12. The plate was washed with 200 ul Wash Buffer 2 times. The removing of 
Wash Buffer was performed by vacuum. 
13. 50 ul of Detection Antibody Coctail were added each well. 
14. The plate was sealed with aluminium foil, and incubated on a plate shaker for 
1 hour at room temperature. 
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15. 50 ul Streptavidin-Phycoerythrin were added each well. 
16. The plate was covered with aluminium foil, and incubated with agitation on a 
shaker for 30 minutes at room temperature. 
17. The content was removed by vacuum. 
18. The plate was washed with 200 ul Wash Buffer two times and the Wash 
Buffer was removed by vacuum. 
19. 100 ul of Sheat Fluid were added each well. The plate was covered with 
aluminium foil and resuspended the beads on plate shaker for 5 minutes. 
20. The plate was read on Luminex Instrument. 
 
2.2.7 Experiments 
Experiment 1  
Cells incubated with 14C-bovine serum albumin to measure the amount of 
protein removed during washing 
14C-bovine serum albumin (14C-BSA) was used as a marker for macromolecules. A 
known concentration of 14C-BSA, which can be detected by scintillation counting, 
was added to the medium and the amount of 14C-BSA was monitored. The amount of 
14C-BSA removed can be compared with the amount of the total of proteins removed.  
Experiment 1a 
Protocol 1a 
1. Myotubes were seeded and differentiated in three 12 well plates as described 
above. 
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2. After the myotubes were differentiated for four days the wells were added 1                     
mL radiolabelled medium and incubated in 37˚ C, in 5 % CO2 for 24 hours. 
The concentration of 14C-BSA in the medium (M3) added was 0.0025 uCi/mL.   
3. The next day the media in which the myotubes had incubated, were transferred 
to separate vials.  
4. The wells were washed 1 to 12 times with DMEM (37˚C). Three and three 
wells were washed the same number of times, so the first 12 well plate had 1 
to 4 washes, the next 5 to 8 washes and the last 9 to 12 washes. 
5. The media were removed from each well approximately 20 seconds after 
addition.  
6. The cells were given 1 mL DMEM and were incubated in 37 ˚C, in 5% CO2 
for 24 hours and the media were then transferred to vials.  
7. The cells were given 1 mL 2 % Triton X-100 and incubated in 37 ˚C, in 5% 
CO2 for 5 minutes. The wells were scraped thoroughly by using a small 
rubber scraper.  
8. The lysates were transferred to vials.  
9. The radioactivity in the media and lysate were measured in Wallac Microbeta 
Trilux. 
Experiment 1b 
Protocol 1b 
1. Myotubes were seeded and differentiated in a 12 well plate as described 
above.  
2. After the myotubes were differentiated for four days three of wells were added 
1 mL radio labelled medium and incubated in 37 ˚ C, in 5 % CO2 for 24 hours. 
The concentration of 14C-BSA in the medium (M3) added was 0.086 uCi/mL.   
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3. The next day the media, which the myotubes had incubated in, were 
transferred to separate vials.  
4. Each of the three wells was washed nine times with 1 mL DMEM. Media was 
added and removed after approximately 20 seconds and transferred to different 
vials. The entire medium used by washing the cells was collected.  
5. The cells were given 1 mL 2 % Triton X-100 and incubated in 37˚ C for 5 
minutes, the wells were scraped thoroughly by using a small rubber scraper.  
6. The lysate were transferred to vials.  
7. The radioactivity in the media and lysate were measured in Wallac Microbeta 
Trilux. 
Experiment 2 
Measuring Lactate dehydrogenase (LDH) activity in the media from myotubes 
being washed  
Protocol 2a 
1. Human satellite cells were seeded out on a 12-well plate as described above. 
Nine of the 12 wells were used. 
2. After the myotubes were differentiated for 5 days they were washed by adding 
and removing 1 mL DMEM 3, 6 or 9 times. The wash solutions were collected 
in different vials. Three wells got the same exposure. 
3. Thereafter the cells were incubated in 1 mL DMEM for 24 hours.  
4. The day after the media were transferred to eppendorf vials and centrifuged on 
3000 rpm for 5 min.  
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5. The myotubes were given 1 mL 2 % Triton X-100, incubated at 37˚ C in 5% 
CO2 for 5 minutes and the wells were scraped thoroughly by using a small 
rubber scraper. 
6. LDH was measured (as described above) in the media and related to that of 
total LDH released after complete cell lysis 
 
Protocol 2b 
The next experiment we did was the same as above with a few modifications.  
1. Human satellite cells were seeded out on one 12-wells plate (as described 
above). 
2. After five days differentiation the wells were washed with 1 mL DMEM 0, 3, 
6 or 9 times.  
3. The myotubes were given 0.5 mL DMEM and incubated 24 hours.  
4. The myotubes were visually investigated under microscope.  
5. The media were centrifuged on 3000 rpm for 5 minutes.  
6. The amount of LDH was measured in the supernatant. The myotubes were 
given 0.4 mL 2 % Triton X-100 and incubated at 37 ˚ C for 5 minutes, and the 
wells were scraped thoroughly by using a small rubber scraper. The cell lysate 
were transferred to vials and LDH and protein were measured. 
7. LDH was measured in the media and related to that of total LDH released after 
complete cell lysis 
Experiment 3  
Measure LDH in the media from myotubes with different differentiation status 
and incubated in media without serum for different periods of time. 
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Protocol 3 
1. Human satellite cells were seeded in three 12 well plates as described above.  
2. The muscle cells were differentiated for 0, 2 and 5 days and washed two times 
by adding and removing 1 mL DMEM. 
3. The muscle cells were added 450 ul DMEM and incubated in 6 or 18 hours. 
4. The media was removed and centrifuged for 5 minutes by 3000 rpm.  
5. The wells were added 1 mL PBS, the PBS was removed and the myotubes 
were lysated in 450 ul 2% Triton X-100. The wells were scraped thoroughly 
by using a small rubber scraper. 
6.  LDH in the supernatant was measured and related to the LDH measured in the                          
cell lysis. 
Experiment 4 
IL-6 concentrations in the media from myotubes with different differentiation 
status and incubated in media without serum for different periods of time 
Frozen supernatants from experiment 3 were thawed and IL-6 concentrations were 
measured using commercially available solid phase, high-sensitivity enzyme-linked 
immunosorbent assay (ELISA) (as described above). 
 
 
Experiment 5 
IL-6 concentration in media from myotubes incubated 6 hours with and without 
BFA  
Protocol 5 
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1. Human satellite cells were seeded out in two 12 well plates as described 
above.  
2. Five days differentiated myotubes were washed six times with 1 mL DMEM 
3. 400 ul DMEM or 400 ul DMEM with 5ug/mL BFA were added.  
4. The myotubes incubated in 0, 3 and 6 hours and the media were removed and 
centrifuged by 3000 rpm for 5 minutes. 
5. The myotubes were added 100 ul 2 % Triton X-100 and incubated in 37 ˚ C 
for 5 minutes.  
6. IL-6 concentrations were measured in the supernatants 
7. LDH amounts were measured in the supernatants and lysates. 
Experiment 6 
IL-6 concentration measured in media from myotubes incubated 6 hours in 
different concentration of BFA  
Protocol 6 
1. Human satellite cells were seeded out in a 12 well plate as described above.  
2. Myotubes differentiated five days were washed 6 times with 1 mL DMEM and 
incubated 6 hours in 400 ul with different concentrations of BFA (1-5 ug/mL)  
3. The media got centrifuged at 3000 rpm for 5 minutes 
4. Concentrations of IL-6 were measured in the supernatant derived from 
myotubes incubated with the different concentrations of BFA. 
5. The myotubes were added 100 ul 2 % Triton X-100 and incubated in 37 ˚ C 
for 5 minutes.  
6. LDH activities were measured in the supernatants and lysates 
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Experiment 7 
Myostatin concentration in media from myotubes incubating 6 and 18 hours 
without serum 
Frozen supernatants from experiment 3 were thawed and myostatin concentrations 
were measured by RD 193058100 Human Myostatin ELISA. Samples of each 
supernatant were taken out and myostatin concentration determined. 
Experiment 8 
IL-6 concentration in the supernatant when the myotubes incubated different 
periods with no serum 
Protocol 8 
1. Human satellite cells were seeded out in two 12 well plates as described 
above.  
2. Myotubes differentiated five days were washed 6 times with 1 mL DMEM and 
incubated different periods of time; 0, 1, 3, 6, 9, 24, 48 and 72 hours in 400 ul 
DMEM  
3. The media were removed to different vials after incubating and the vials were 
centrifuged by 3000 rpm for 5 minutes. 
4. 200 ul supernatant were transferred to 96 well plate and IL-6 was measured 
5. 25 ul supernatant were transferred to 96 well plate and LDH was measured 
6. Each of the wells was added 100 ul 2% Triton X-100, incubated 5 minutes in 
37 ˚ C for 5 min. 
7. 20 ul of each lysate were transferred to the 96 well plate which is used for 
LDH measurement. 
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8. 50 ul of each lysate were transferred to another 96 well plate and the protein 
concentrations were determined. 
Experiment 9 
IL-6 concentration in the media from myotubes incubated in medium with high 
and low glucose concentration and with or without BFA. 
Protocol 9 
1. Human satellite cells were seeded out in two 12 well plates as described 
above.  
2. Myotubes were differentiated for five days 
3. The wells were washed six times with 1 mL DMEM. 
4. The myotubes were incubated for six hours in 400 ul medium with 1 mM, 5 
mM and 20 mM glucose, and half of the wells were given insulin. And half of 
these six different treatments were given 1 ug/mL BFA. 
5. After 6 hours the medium was removed, centrifuged and IL-6-concentraton 
was measured on the supernatant. 
6. The myotubes were given 2% Triton X-100, incubated in 37˚C, in 5 % CO2 
for 5 min. 
7. The amount of protein was measured on the cell lysate. 
Experiment 10 
Incubation with high and low glucose with and without BFA  
Protocol 10 
1. The myotubes were seeded out on 12 well plates as described above 
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2. Two days differentiated myotubes were preincubated with either 5 mM or 20 
mM glucose for four days.  
3. The myotubes were washed 6 times with 1 mL DMEM. 
4. The myotubes incubated in 400 ul DMEM or DMEM with 1 ug/mL BFA for 6 
hours. 
5. The media were transferred to vials centrifuged by 33300 rpm for 40 minutes 
in 10˚ C.  
6. The supernatants were frozen in - 20˚C and sent to Aker University Hospital in 
dry ice for proteomic analyse. 
 
Proteomics at Aker University Hospital 
The proteins from supernatants from donor 29 and 37 incubated with BFA were 
concentrated from 2 mL to 60 ul and 50 ul, respectively. The upconcentration of 
supernatants from myotubes incubated without BFA resulted in higher final volume 
after the concentration with the same cut-off value, because these supernatants 
contained higher concentration of protein. 2 mL of the supernatants derived from 
myotubes incubated without BFA ended up with 100 ul from both ID 29 and 37. This 
was not adjusted before the electrophoresis was performed. The samples were 
concentrated by centrifugation through membranes with a cut-off of 10 kDa. SDS-
PAGE and two-dimensional electrophoresis were performed at Hormonlaboratoiet at 
Aker University Hospital. 
Proteins were separated according to their molecular weight in SDS-PAGE using 
NuPAGE 4-12% Bis-Tris gels (Invitrogen). In two-dimensional electrophoresis the 
proteins were first separated by isoelectric focusing using Immobiline DryStrip pH 3-
10. 7 cm (GE Healthcare) which was rehydrated in 7M urea, 2M thiourea, 4 % 
CHAPS, 0.2% Pharmalytes and 1.5 mg/mL DTT. The samples (10 ul) were added 
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rehydration buffer (115 ul) and applied along the whole strip and rehydrated over 
night. The focusing was run with a Bio-Rad Protean IEF Cell (Bio-Rad). After the 
focusing the strips were equilibrated in LDS sample buffer (Invitrogen) containing 
reducing and alkylating solutions and the proteins were applied to SDS-PAGE as 
described above. Proteins were visualized by staining either with Coomassie or silver. 
Magic Mark protein standard (Invitrogen) was used to estimate molecular weights. 
The proteins from the gel were further characterized by Matrix-assisted laser 
desorption/ionization-time of flight mass spectrometer (MALDI-TOF). 
Experiment 11 
Protocol  
1. Satellite cells from donor 29 were seeded out in two 12 well plates and donor 
30 and 37 were seeded out in four 175 cm² flasks.  
2. Myotubes differentiated five days were washed six times with 1 mL DMEM in 
each well for the 12 well plate and 15 mL for the 225 cm² flasks. 
3. The wells were added 0.4 mL DMEM or DMEM with 1 ug/mL BFA, and the 
flasks were added 15 mL DMEM or DMEM with 1 ug/mL BFA and incubated 
for six hours. 
4. The medium were centrifuged for 5 minutes on 4000 rpm. 
5. Cytokines in the conditioned media were analysed by Luminex multiplexing 
technology. 
6. The concentration of protein in the lysate was measured. 
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3. Results 
Our aim was to identify novel myokines in growth media conditioned by human 
myotubes. First, the myotube culture conditions had to be determined. Second, we 
validated our cell model with respect to myokine secretion by measuring IL-6, a 
previously identified myokine. Finally, we collected myotube conditioned media 
which were analyzed using a proteomics approach. 
 
3.1 Eliminating FCS in media by pre-washing cells  
Human myotubes are normally cultured in the presence of FCS. For the purpose of 
proteomics, we needed to generate conditioned media containing proteins derived 
from myotubes alone, without FCS. When switching from media containing FCS to 
media without FCS, the cells need to be washed by repetitively adding and removing 
media (DMEM).  
We measured how many times the cells needed to be washed prior to conditioning of 
the media to diminish the background noise from FCS proteins (mainly BSA) during 
2D-gel electrophoresis. The washing procedure would also need to be gentle enough 
to avoid stress and cell death. To find out how many times we should wash the 
myotubes to remove appropriate amount of serum proteins we used radiolabelled 14C-
BSA as a marker for BSA and other macroproteins in media. Myotubes were first 
incubated with 14C-BSA and then washed 9 times in the media. The washing 
solutions were collected and their levels of radioactivity were measured (Figure 1).  
After removal from the cells, the media in which the myotubes had been initially 
incubated contained 98 % of the total 14C-BSA (wash # 0). The radioactivity 
measured in the first and second wash solution contained 1.5 and 0.1 % of the total 
radioactivity, respectively (Figure 1, logarithmic scale). Washing solution number 3 
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to 9 contained < 0.05 % of the total 14C-BSA (Figure 1). 
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Figure 1. Amount of 14C-BSA removed from cultured human myotubes during washing. After 4 days of 
differentiation human myotubes were incubated with 14C-BSA and then washed 9 times. The diagram shows 
radioactivity, as a measure of 14C-BSA, in washing solutions # 1-9 relative to the total in all 9 washing 
solutions.  The experiment was performed in triplicates and each point represents mean ± SEM. The Figure is 
representative of two similar experiments.  
 
In our search for new secretory proteins from myotubes it was important to monitor 
what condition the cells were in. Damaged or dead myotubes might contaminate the 
conditioned media with intracellular proteins. LDH is an intracellular enzyme, which 
leaks out of the cell when the membrane is damaged. To explore how washing 
influenced plasma membrane integrity, we measured LDH activity in the media.  
Human myotubes were washed by adding and removing washing solution 3, 6 or 9 
times. After this rinsing, the myotubes were cultured for another 24 hours and LDH 
activity was measured (materials and methods, experiment 3 and Figure 2). 
Relative LDH activity was 7.0 %, 3.5 % and 2.0 % after 3, 6 and 9 washes, 
respectively (Figure 2). Increasing the number of washes from 3 to 9 reduced LDH 
activity significantly (P = 0.03). 
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Figure 2. LDH activity in supernatants from myotubes exposed for three levels of washing. Human 
myotubes were washed by adding and removing washing solution 3, 6 or 9 times and incubated in medium 
(DMEM) for 24 hours. The conditioned media were collected and the diagram shows the LDH activity 
measured in the media related to the total LDH activity measured in lysed cells (relative LDH activity). The 
experiment was done once in triplicates and each point represents mean ± SEM.  
Because LDH activity was expected to rise with increasing number of washes we 
measured an additional variable to see if cells had been lost during the washing 
procedures. Protein content in cell lysates is an indicator of the amount of cells. 
Therefore, we compared the amount of total cellular proteins in cells after different 
washing exposure.  
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Figure 3. Protein concentration in the lysate of the myotubes after exposure of different levels of 
washing. The myotubes were washed 3, 6 and 9 times with washing solution and incubated for 24 hours. The 
bars represent protein concentration measured in total cell lysates (mean ± SEM) of one experiment performed 
in triplicates. 
The protein concentrations measured in the lysates after exposure of 3, 6 or 9 washes 
were 68.0, 64.9 and 59.1 ug/mL, respectively (Fig 3). Lysates from myotubes 
exposed to 9 washes had statistically less protein content than lysates from myotubes 
exposed to 3 washes (P = 0.037).  
We also observed in the microscope that increasing the number of washes tended to 
reduce the number of cells attached to the culturing surface.  
 
3.2 Optimal incubation with FCS-free media  
The length of incubation under serum-free conditions is a trade-off between two 
time-dependent processes: 1) maintenance of cell integrity and 2) reaching detectable 
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levels of secretory proteins in the conditioned medium. We therefore monitored these 
two parameters at different time-points. 
The medium routinely given cultured human myotubes contains FCS. However, we 
had to incubate the myotubes in protein-free conditions to avoid detection of proteins 
derived from FCS during proteomic analysis. We had to find out how the myotubes 
were influenced by serum-free conditions over time.  
We incubated undifferentiated muscle cells and myotubes differentiated for 2 and 5 
days in medium with no serum for 6 or 18 hours. To evaluate how incubating 6 and 
18 hours with no serum influenced plasma membrane integrity, relative LDH 
activities were determined (Figure 2). 
0
10
20
30
40
50
60
70
0 2 5
Days of differentiation
R
el
at
iv
e 
LD
H 
ac
tiv
ity
 (%
)
6 h
18 h
 
Figure 4. LDH activity in media from myotubes incubated 6 or 18 hours without FCS.  Myotubes 
differentiated 0, 2 or 5 days were incubated in medium with no serum for 6 or 18 hours. The bars show mean 
relative LDH activity ± SEM (n=5).  
 
The relative LDH activity in the media was three times higher after 18 hours 
compared to 6 for myotubes differentiated 5 days.  
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Myotubes differentiated 0 and 2 days had in general less relative LDH activity than 
myotubes differentiated 5 days (Figure 4).  
Several studies indicate that IL-6 is secreted from myotubes (14;18). Therefore, we 
chose to measure IL-6 in our media for validation purposes. The aim was to examine 
if IL-6 could be found in media of our cultured myoblasts and myotubes. 
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Figure 5. IL-6 concentration measured in the media from myotubes incubated in medium without FCF 
IL-6 concentration measured in the media from muscle cells differentiated 0, 2 and 5 days and incubated in 
medium without serum for 6 or 18 hours. The bars show mean concentration of IL-6 and standard deviation for 
duplicates from each well (n = 2). 
 
The concentrations of IL-6 in the media of undifferentiated myoblasts were 0.13 
pg/mL and 0.45 pg/mL for 6 and 18 hours incubation period, respectively. 
Myoblasts differentiated 0 days and myotubes differentiated 5 days had 3.5 and 1.8 
times, respectively, higher concentration of IL-6 in the supernatant derived from 
myotubes incubated 18 hours compared with 6 hours. The medium from myotubes 
differentiated 2 days and incubated for 6 hours had 1.0 pg/mL IL-6 which was the 
highest concentration of IL-6 measured in this experiment (Figure 5).  
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For undifferentiated cells and for cells differentiated in two days, the relative LDH 
activities were below 10 % for both 6 and 18 hours incubation. For 5 days 
differentiated myotubes the relative LDH activity after 6 hours incubation was 20.1 
% and for cells incubated 18 hours the percentage increased to 66.4 (Figure 4). 
 
3.3 Effect of BFA on IL-6 release 
We wanted to study proteins secreted, and not released due to damage, from 
myotubes. BFA is involved in intracellular protein transport and could possible be 
used as a negative control to investigate secretion of proteins from myotubes. This 
experiment (materials and methods, experiment 5) was performed to explore this. 
Myotubes were incubated with and without BFA and the concentrations of IL-6 were 
measured in the media. IL-6 was thus used as a marker for protein secretion, because 
we assumed that if BFA inhibited secretion of IL-6 it would most probably inhibit 
secretion of other proteins as well. 
-0.2
0.8
1.8
2.8
3.8
0 3 6
time (h)
C
on
ce
nt
ra
tio
n 
of
 IL
-6
 (p
g/
m
l)
 - BFA
 + BFA
 
Figure 6. IL-6 concentration measured in the supernatants from myotubes in media with or without 
BFA (5 ug/ml). The bars show mean and SEM from two wells in duplicate (n = 2).  
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The mean concentration of IL-6 from myotubes incubated in medium without BFA 
was 19 times higher than the concentration derived from myotubes incubated in 
medium with BFA, when incubating 3 hours. Myotubes incubated in 6 hours without 
BFA had 11 times higher concentration of IL-6 in the media compared to myotubes 
incubated in media with BFA (Figure 6). 
The lower concentration of IL-6 in the supernatants from myotubes incubated in 
media with BFA compared to the incubation in media without BFA probably 
indicates inhibition of secretion because of BFA. 
 
3.4 IL-6 secretion over time  
Myotubes were incubated in medium with no serum; 0- 72 hours. The amount of IL-6 
was measured in media. 
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Figure 6. IL-6 concentration measured in media from myotubes incubated up to 72 hours in DMEM. 
The spots show mean ± SEM (n=6) concentrations of IL-6 in the media after the different incubation periods 
for the duplicates for three wells. 
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The IL-6 curve was nearly linear the first 6 hours of incubation (Figure 6). The IL-6 
concentration in media after 6 hours was 59.8 % of the IL-6 concentration after 72 
hours. 
The LDH activity increased above twofold from 24 hours incubation to 48 hours 
incubation (Data not shown).   
 
3.5 Optimal concentration of BFA  
The experiment above indicated an extensive reduction of IL-6 concentration in 
conditioned media by 5 ug/mL BFA. Thus, we explored how different concentrations 
of BFA would influence the concentration if IL-6 in the media. Myotubes were 
incubated 6 hours with different concentrations of BFA; 1-5 ug/mL. IL-6 
concentrations were measured in the supernatants (materials and methods, experiment 
6).    
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Figure 7. IL-6 measured in medium from myotubes incubated with different concentrations of BFA.  
The five days differentiated myotubes incubated 6 hours with different concentrations of BFA. IL-6 
concentrations were measured in the supernatants. The bars show mean concentration ± SEM (n=4) for the 
concentrations of IL-6 in the media from two wells in duplicate. 
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The experiment indicated that the lowest concentration of BFA, 1 ug/mL inhibited 
secretion by 87.5 % (Figure 7).  
 
3.6 Myostatin release 
Frozen supernatant from the experiment above (materials and methods, experiment 3) 
were thawed and a sample of each supernatant was taken out and myostatin 
concentration determined by ELISA. Myostatin concentrations in the myotube 
conditioned media were below the detection limit (data not shown). 
 
3.7 Effect of glucose on IL-6 secretion 
We studied whether incubation of myotubes with metabolic parameters as insulin and 
glucose, affected the concentration of IL-6 in media.  
The myotubes were incubated for 6 hours in medium with three different glucose 
concentrations, with and without insulin.  
BFA is a negative control, indicating if the concentrations of IL-6 in the media are 
due secretion or leak. The cells were lysed and the amount of protein was measured 
(materials and methods, experiment 9).  
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Figure 8a. IL-6 concentration measured in conditioned media from myotubes incubated with different 
glucose concentrations. Myotubes differentiated five days in 12 well plate incubated 6 hours in serumfree 
media with 1 mM, 5 mM and 20 mM glucose. The bars show mean ± SEM (n=4) concentration of IL-6 in the 
media after six hours incubation with the different exposures from two experiments using media from one well 
in a duplicate from each experiment. 
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Figure 8b. IL-6 concentration measured in media from myotubes incubated with insulin and different 
concentrations of glucose. Myotubes differentiated five days in 12 well plates incubated in serumfree media 
with 1 mM, 5 mM or 20 mM glucose concentrations with insulin for 6 hours. The Figure shows SEM (n=4)   
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and mean concentration of IL-6 measured in the media (in duplicate) from two experiments using one well 
from each experiment (n=4). 
IL-6 concentrations in media declined with decreasing glucose concentrations when 
insulin was present. The release of IL-6 into the media was not affected when the 
myotubes incubated in the different glucose concentrations without insulin. The 
glucose effect on IL-6 release in media seems to be insulin dependent (Figure 8a, b). 
Incubation of myotubes in different concentrations of glucose (1, 5 and 20 mM) for a 
6 hour showed similar effects on IL-6 concentrations in supernatants without insulin 
(Figure 8b).  IL-6 concentrations in the media were reduced with lower glucose 
concentrations (Figure 8a) in the presence of insulin. 
IL-6 concentration in supernatants from cells incubated with insulin and low glucose 
(1 mM) was 1.1 pg/mL compared to cells incubated with high glucose (20 mM) and 
insulin was 2.3 pg/mL (Figure 8a). 
The media from myotubes incubated with insulin and 5 mM glucose (physiological 
level), had IL-6 concentration of 1.5 pg/mL (Figure 8a). When the myotubes 
incubated in the same glucose concentration (5 mM) but without insulin, the 
concentration of IL-6 in media was 2.0 pg/mL (Figure 8b). 
 
3.8 Secretion of cytokines  
The medium from myotubes incubated with and without BFA were collected. 13 
cytokines in the conditioned media were analysed by Luminex multiplex technology. 
The concentrations of the cytokines were measured and the total amounts of the 
cytokines in the media were estimated. The total amount of the cytokines from the 
well or flask were related to the total amount of protein in the cell lysate from the 
same well or flask (Table 1). The amount of protein in the cell lysate indicated the 
amount of cells remaining after washing and incubation in the well or flask. By 
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relating the amount of cytokines to the amount of protein we adjusted for the eventual 
differences in myotube density in the different wells or flasks. 
The ratio of media volumes (mL) to the growth area (cm2) were 0.11 mL/cm2 for the 
wells and 0.07 mL/cm2for the flasks. The wells had 1.6 times higher volume per cm2 
than the flasks. 
 
Table 1. The amount of cytokines in the media related to the amount of protein in the cell 
lysate from the well or flask (pg cytokine/mg protein) 
 Donor 29 Donor 30 Donor 37 
BFA - + - + - + 
IL-6 21.36± 0.96 1.29±0.08*** 2.65±0.25 0.41#±0.14** 200.56±12.18 2.87±0.11***
IL-8 100.22±2.60 2.64±0.30*** 4.31±.027 0.36±0.05*** 199.13±4.23 2.15±0.14***
IL-7 9.95±1.16 4.19±1.05* 6.73±0.47 6.39±0.84 5.72±0.05 5.05±0.25 
IL-13 
 
10.53±2.15 
 
2.98±0.17* 
 
2.46±0.55 
 
1.93±0.35 1.74±0.00 1.44±0.02***
IL-10 0.15#±0.08 0.25#±0.10 0.21#±0.09 0.42#±0.17 0.47#±0.07 0.16#±0.05 
GM-CSF 0.91#±0.13 0.63#±0.09 0.73#±0.13 0.42#±0.08 0.52#±0.05 0.33#±0.06 
TNFα ND ND ND ND ND ND 
IL-1β ND ND ND ND ND ND 
IFNγ ND ND ND ND ND ND 
IL-12 ND ND ND ND ND ND 
IL-2 ND ND ND ND ND ND 
IL-4 ND ND ND ND ND ND 
IL-5 ND ND ND ND ND ND 
The mean values ± SEM are based on triplicate measurements (except for donor 37 without 
BFA which are based on duplicates),  ND = not detectable, # extrapolated values, * < 0.05, **  
< 0.01, *** < 0.001 
 
 
IL-6, IL-8, IL-7 and IL-13 were detected in this analysis. IL-6 and IL-8 had also 
significantly different values in media from myotubes incubated with BFA compared 
to without.  
Supernatant from donor 29 contained the highest concentration of IL-13 per mg 
protein compared to the other donors. The mean IL-13 concentration in media from 
myotubes from donor 29 incubated without BFA was 10.5 pg/mL and had more than 
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3.5 times higher concentration related to the mean concentration of IL-13 in media 
from myotubes derived from donor 29 incubated in BFA.  
Together with the conditioned media from myotubes, supernatants from hepatocytes 
and adipocytes were also tested in the same Luminex multiplex analysis. The medium 
from myotubes was the only medium that showed IL-13 within range of standard 
curve.  
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3.9 Proteomics of myotubes conditioned media  
3.9.1 Proteomics of media after preincubation in different glucose 
concentrations 
Myotubes were preincubated in either 5 mM or 20 mM glucose for four days. The 
myotubes were incubated 6 hours with or without BFA. The supernatants were 
transferred to vials, frozen and sent to Aker University Hospital for proteomic 
analysis. 
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Figure 9. Silverstrain. Row 1 and 2 show molecules from myotubes incubated without BFA and row 3 and 4 
show molecules from myotubes incubated in BFA. Molecules in row 1 and 3 derive from control (5 mM 
glucose) and row 2 and 4 derive from myotubes incubated in high glucose (20 mM). 
The media from myotubes incubated with BFA (row 3 and 4 Figure 9) gave fewer 
proteins (bands) than the two others. Compared to the control (row 1, Figure 9) we 
can se two more bands from myotubes incubated with high glucose (row 2, Figure 9) 
in the range around 50-60 kDA. These bands were not visible in media from 
myotubes incubated with BFA. This indicated a secretion inhibition as a consequence 
of BFA. 
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3.9.2 Proteomics of media from myotubes incubated with and 
without BFA  
Myotubes were incubated 6 hours with or without BFA, and the conditioned medium 
were analysed by two-dimensional electrophoresis. 
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Figure 10.  Two-dimensional electrophoresis. Differentiated myotubes were incubated in media without 
BFA (left panel) and media with BFA (right panel). The molecules from the conditioned media were first 
separated by isoelectric focusing and then on size. 
 
Comparing the pictures we can see 9 spots more when the myotubes were incubated 
without BFA. The media from myotubes incubated without BFA contained high 
concentrations of protein compared to the media derived from myotubes incubated 
without BFA. The high protein concentrations lead to clotting of the filters when the 
concentration of the proteins took place. This resulted in a poorer concentration and a 
higher final volume with the same cut-off value for media derived from myotubes 
incubated without BFA. The proteins from media from myotubes from donor 29 and 
37 incubated with BFA were concentrated from 2 mL to 60 ul and 50 ul, respectively. 
For both donors incubated without BFA 2 mL media ended up with 100 ul. Because 
of no adjustment before the electrophoresis was performed, the gel pictures showed 
weaker differences between media from myotubes incubated with and without BFA 
than there really were. 
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4. Discussion 
4.1 Myotubes used for myokine proteomics 
In the present study we explored release of myokines from human skeletal muscle 
cells in culture. Examination of many different proteins and pathways in cultured 
muscle cells suggest that, although some differences exist, that these cells contain 
much of the same proteins and signaling systems as mature muscle fibers. Thus, this 
model of primary human skeletal muscle cells is a useful and physiological relevant 
model to use for the study of proteins secreted from human muscle tissue (30), 
although contractions, which take place in vivo, are not present.     
Initially it was important to determine the appropriate number of rinses each well 
should receive to remove a sufficient amount of protein contamination derived from 
the growth medium (containing 2% serum, FCS), without harming the myotubes 
growing on the bottom. Reducing background noise, mainly albumin, was necessary 
before 2-D gel electrophoresis took place. Two experiments using 14C-labelled-BSA 
were performed to estimate the amount of protein removed by the washes. Not 
surprisingly the conclusion was that the more we washed the cells the more proteins 
were removed. 
Our data indicated that the LDH activity in media went down with increasing washes. 
It is not reasonable that the myotubes would leak less LDH with increasing exposure. 
One hypothesis was that the washing in addition to eliminating proteins in media, 
removed weak or damaged muscle cells and that the myotubes remained attached to 
the culturing surface were more robust and leaked less LDH. That could be the 
explanation for why the relative LDH activity went down when the washing exposure 
increased.  
Medium containing proteins from FCS is routinely given cultured human myotubes. 
When assessing how long time the myotubes should incubate without FCS to search 
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for new myokines, we first explored the relative LDH activity, and found that it was a 
3.3 times higher relative LDH activity for 5 days differentiated myotubes incubated 
18 hours compared to 6 hours. When emphasizing cell integrity we concluded that 6 
hours is more gently than 18 hours. 
Because the concentration of peptides and proteins in the media could be low and 
difficult to measure we wanted to find the optimal method for collecting media 
containing as much protein derived from myotubes as possible. To validate our model 
we measured the known myokine, IL-6. We performed a time course of the IL-6 
concentration in the media, which indicated that the release of IL-6 was nearly linear 
up to 6 hours. We decided to incubate the myotubes for 6 hours also when we 
searched for other myokines. It is possible that novel myokines will display different 
release patterns than IL-6, and thus will require longer or perhaps shorter incubations 
for optimal detection, but after 6 hours incubation we show that at least one myokine 
is detectable. 
 
4.2 Search for novel myokines 
4.2.1 Immunodetection of myokines involving ELISA 
As indicated in previous studies we also detected IL-6 as a protein secreted from 
human myotubes in culture. We first observed IL-6 in media from the myotubes 
which was the first sign that our model could be appropriate for detecting myokines. 
Later we demonstrated the interesting phenomenon that the concentration of IL-6 in 
media dramatically decreased when the myotubes were incubated in BFA. 
Because previous work indicate that IL-6 is released from myotubes and the release is 
enhanced by low glycogen stores (19), we expected a higher concentration of IL-6 in 
media from myotubes incubated with low glucose concentration compared to high 
glucose concentration. We observed the opposite of what we expected; decreased IL-
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6 secretion from myotubes incubated in lower glucose concentration when insulin 
was present.  
Insulin seems to facilitate a regulatory role of glucose on the release of IL-6 through a 
yet unknown mechanism. One could speculate that perhaps during low extracellular 
glucose concentrations, insulin is able to shunt the intracellular flow of glucose in 
such a way that the stimuli maintaining basal IL-6 release conditions is reduced.  
ChREBP is a transcription factor known to be activated by xylose-5-phosphate (a 
metabolite in the pentose phosphate branch deriving from glucose-6 phosphate). One 
hypothesis could be that ChREBP activity is important for IL-6 synthesis and/or 
release, and is reduced when xylose-5-phosphate levels drop due to the combined 
effect of low extracellular glucose and high insulin. This however, remains to be 
elucidated in future experiments.  
It is important to remember that a situation where insulin is kept high while the 
glucose concentration is low, might not be very physiological relevant. As well as the 
fact that during fasting basal insulin levels never drop to zero, thus future 
experiments might consider adjusting these parameters within a physiologic range. 
 
4.2.2 Proteomic approach involving 2D-PAGE and MALDI-ToF  
The gel pictures show more spots for the media from myotubes incubated without 
BFA (Figure 11). This indicates that the BFA inhibits secretion and that our model is 
appropriate to explore the secretion of proteins from myotubes.  
By the method and analyses used for detecting novel myokines, we did not have 
enough material to identify the proteins visual in the gel-pictures. The challenge for 
future experiments is to find a way to apply more secretion material to the gel to 
make it possible further to identify the proteins by MALDI-TOF.   
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Supernatant from one donor was analysed both by Luminex multiplexing technology 
and 2D-PAGE. The results from the Luminex analysis showed that the concentration 
of IL-6 in the supernatant was 80.6 pg/mL. This means that the concentration from 2 
mL to 100 ul, ends up with the concentration of 1.6 pg IL-6 /ul. 10 ul and estimated 
16.1 pg IL-6 were applied to the gel. This amount was enough to visually detect 
proteins by 2D-PAGE, but not further to identify the secretion products by MALDI-
TOF. We have to add more protein to the gel to exceed the detection limit. When 
analysing by 2D-PAGE 10 ul was applied. We need 300 pg protein to further 
characterise the protein by MALDI-TOF. In this example we would need 20 times 
more protein. To achieve these criteria we could try to centrifuge on a higher speed to 
remove cell compartments, which could improve the concentration of the media by 
avoiding the filter to plug and end up with a higher concentration of the secretion 
products. It is also possible to apply a higher volume to the gel. We can also try to 
use different cut-off values and separate the proteins before applying the gel, to 
achieve higher concentration of the different proteins.  
By choosing 10 as cut-off value we could miss the possible small signal molecules 
present in media. Future experiments should also search for smaller proteins or 
peptides. 
  
4.2.3 Immunodetection involving Luminex multiplexing technology  
IL-6 is a known myokine(14;18;28;31). We wanted to find out if we could detect 
some other known cytokines in the media from the myotubes. We tested 13 different 
cytokines in the media from myotubes by Luminex multiplexing technology. IL-6, 
IL-8, IL-7 and IL-13 were detectable.  
IL-8 is suggested as a possible myokine in other studies (32;33). IL-8 is a known 
chemokine that attracts primarily neutophils. In addition to its chemokine properties 
IL-8 acts as an angiogenic factor (34). The concentration of IL-8 increases in plasma 
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in response to exhaustive exercise (32). After 3-hours exercise IL-8 mRNA increased 
several-fold compared to preexercise (35). IL-8 is also detected in media from 
myoblasts isolated from biopsies from patients with suspected myopathy (29). In our 
study we measured IL-8 in media from human myotubes in culture and the 
concentration decreased dramatically when the myotubes were incubated in BFA 
(Table 1). This indicates that IL-8 probably is secreted from myotubes, and therefore 
can be classified as a myokine.  
IL-7 is a key cytokine in the immune system, essential for normal development of B 
cells and T cells. IL-7 is secreted by stromal cells of the red bone marrow and thymus 
(36). We detected IL-7 in the medium from myotubes in culture (Table 1). 
IL-13 is a key inducer of several cytokine-dependent pathologies. Inflammation, 
mucus production, tissue remodeling, and fibrosis are regulated by IL-13. IL-13 was 
identified as the primary mediator of liver fibrosis (37). We detected IL-13 in media 
from myotubes and observed that the concentration decreased after incubation in 
BFA (Table 1) which indicates that the release possible is due to a secretion. 
 
4.2.4 Concluding remarks 
We have during this work optimized several conditions important to consider when 
using myotubes as a model for identifying novel myokines. Myotubes have been used 
as an in vitro model of skeletal muscle for many years, and are therefore well suited 
for finding, identifying and studying new muscle derived cytokines (myokines). 
Based on our studies (and previous protocols) 5 days of differentiation was 
considered sufficient to ensure optimal differentiation of the myoblasts into 
myotubes. 
We conclude from our studies that in the search of novel myokines, human 
myotubes in culture should be washed 6 times to remove protein from the serum 
added the media, and the incubation period in medium without serum should be 6 
 57
hours to collect medium where we at least know that the concentration of IL-6 is 
detectable. 
 
The detection of novel myokines by proteomics should be further optimized. Some of 
the changes could be to centrifuge the media at a higher speed to remove cell 
particles. Another issue is the problem of up-concentrating the samples as to apply 
more proteins to the gel. This could be done perhaps by using different filters that can 
filter larger fractions or by more efficient precipitations techniques. The proteins and 
peptides could also perhaps be separated by size before application to the gel. 
In addition to IL-6 we detected some potentially new myokines which are; IL-7, IL-8 
and IL-13. Our studies support the theory that myotubes release proteins with 
hormonal functions, and that the release perhaps can be influenced by different 
energy carrying metabolites. Further studies are required to explore the role muscle 
tissue has in promoting good health and regulating metabolic pathways in the human 
body. 
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